Figure 1From: Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancerIHC for Her-2 protein expression. Figure 1 (A) Completely negative, IHC0; (B) Faint membranous positivity, ICH1+; (C) Moderate membranous positivity, IHC2+; (D)Strong, more than 30% tumor cells with circumferential membranous positivity, IHC3+.Back to article page